Date: 07 Feb 2025
Hall B |
| Time |
Topic |
Speaker |
Chairpersons |
| 14:00 - 15:00 |
HF - AREAS OF CONCERN
|
|
MANISH KUMAR JHA NEERAJ BHALLA AMIT SHARMA George Koshy A ARUN KUMAR G DILEEP |
| 14:00 - 14:10 |
FREQUENT VPCS AND HEART FAILURE
|
Abhilash T G |
|
| 14:10 - 14:20 |
POST COVID DCM-HYPE OR REALITY
|
Sunil Modi |
|
| 14:20 - 14:30 |
HF-A RISK FOR MALIGNANCY ?
|
TANUJ BHATIA |
|
| 14:30 - 14:40 |
WHEN AND HOW TO EVALUATE FOR CAD IN HF
|
SUNIL ROY THOTTUVELIL |
|
| 14:40 - 14:50 |
OSA IN HF - APPROACH
|
ADITI SINGHVI |
|
| 14:50 - 15:00 |
HYPERTROPHIED HEART-IS IT FABRY'S
|
NAVEEN MATHEW |
|
| 15:00 - 16:00 |
NEWER CONCEPTS IN HF
|
|
VATCHALA SREE Sunil Thanvi RAJASEKHAR P HIMAL RAJ PRIYANK RASTOGI HARIKRISHNAN KURUP |
| 15:00 - 15:10 |
PERSISTENTLY ELEVATED TROPONIN IN HF
|
James Thomas |
|
| 15:10 - 15:20 |
HF BEYOND EF-CURRENT UNDERSTANDING
|
Jimmy George |
|
| 15:20 - 15:30 |
DERANGED CREATININE ON ARNI-FRIEND OR FOE?
|
RITUPARNA SHINDE |
|
| 15:30 - 15:40 |
FRAILITY AND HF
|
JAY SHAH |
|
| 15:40 - 15:50 |
CMR IN HF-IS IT UNDERUTILISED
|
NAGESH C M |
|
| 15:50 - 16:00 |
PROGNOSTIC SIGNIFICANCE OF TR IN HF
|
Ramdas Nayak |
|
| 16:00 - 17:00 |
CHALLENGES IN HF THERAPY
|
|
ADITI SINGHVI NAVEEN MATHEW KRISHNAMOORTHY K M George Koshy A PRAKASH NEGI NIGIL CLETUS |
| 16:00 - 16:10 |
POST MVR TRICUSPID VALVE DISEASE - EVALUATION AND PROGNOSIS
|
Cibi Issac |
|
| 16:10 - 16:20 |
NAFLD AND THE RISK OF HFpEF: THE LIVER HEART CONNECTION
|
JO JOSEPH |
|
| 16:20 - 16:30 |
HYPONATREMIA IN HF-HOW TO MANAGE?
|
ANOOP GEORGE ALEX |
|
| 16:30 - 16:40 |
MANAGEMENT OF HYPERKALEMIA AND HEART FAILURE
|
Sunil Thanvi |
|
| 16:40 - 16:50 |
ACETAZOLAMIDE IN HF
|
Placid Sebastian |
|
| 16:50 - 17:00 |
BOLUS VERSUS CONTINOUS INFUSION OF DIURETICS IN HF
|
RAJESH T |
|
| 17:00 - 18:00 |
CHANGING TRENDS IN HF
|
|
TANUJ BHATIA Arun B S SUDHEER M D NARRA LAVANYA Anil Balachandran APARAJITA KUMAR |
| 17:00 - 17:10 |
CHOOSING DIFFERENT BETA BLOCKERS
|
Natesh B H |
|
| 17:10 - 17:20 |
OPTIMUM HR IN HF AND NSR
|
John F John |
|
| 17:20 - 17:30 |
REVERSIBLE CAUSES OF NON ISCHEMIC HF
|
DEEPAK PADMANABHAN |
|
| 17:30 - 17:40 |
CONGESTION MANAGEMENT IN HF &DIURETIC RESISTANCE
|
PRABHAKAR D |
|
| 17:40 - 17:50 |
NEWER DEVICES IN HF
|
Stigi Joseph |
|
| 17:50 - 18:00 |
EPICARDIAL ADIPOSE TISSUE IN HF- MEDIATOR OR RISK FACTOR?
|
UDAY JADHAV |
|
| 18:00 - 19:00 |
HF THERAPY - BEYOND THE USUAL
|
|
PRAMOD V K RAJESHWARI NAYAK RITUPARNA SHINDE JAYARAJAH M MILIND SHRIVASTHAVA JYOTHI VIJAY |
| 18:00 - 18:10 |
METABOLIC MODULATION IN HF
|
Shantanu Sengupta |
|
| 18:10 - 18:20 |
ATRIAL FUNCTIONAL MITRAL REGURGITATION-DIAGNOSIS AND THERAPEUTIC APPROACHES
|
NARRA LAVANYA |
|
| 18:20 - 18:30 |
REMOTE MONITORING IN HEART FAILURE, PAST, PRESENT, AND FUTURE
|
Arun B S |
|
| 18:30 - 18:40 |
HF IN CKD AND SEPSIS
|
Manu R Varma |
|
| 18:40 - 18:50 |
EXERCISE TRAINING FOR HEART FAILURE
|
Johny Joseph |
|
| 18:50 - 19:00 |
INTER-ATRIAL SHUNT FOR TREATMENT OF HFrEF AND HFrEF
|
NAGENDRA BHOOPATHY S |
|
| 19:00 - 19:30 |
HF - QUESTIONS TO ANSWER
|
|
JAIN T SAJI SUBRAMANIAM Geevar Zachariah Ramdas Nayak YUGAL K MISHRA ANURADHA SRIDHAR |
| 19:00 - 19:10 |
MRA IN HFpEF - TIME TO REWRITE THE GUIDELINES?
|
YOUSUF KUMBLE |
|
| 19:10 - 19:20 |
CARDIORENAL IMPACT OF SGLT-2 INHIBITORS: SHOULD WE WORRY ABOUT GFR
|
Suresh K |
|
| 19:20 - 19:30 |
MRA IN HF
|
PRASANNA KUMAR C K |
|
| 19:30 - 20:30 |
CURRENT THERAPEUTICS
|
|
Geevar Zachariah ARUN KUMAR SUBBAIAH TEFFY JOSE SOMASEKHAR G SUNIL SIVADAS SAJEEV C G |
| 19:30 - 19:45 |
FCM IN HF
|
Anil Balachandran |
|
| 19:45 - 20:00 |
ACHIEVING OPTIMAL HEART RATE IN HFrEF
|
JABIR A |
|
| 20:00 - 20:15 |
RESTORE HF
|
Ponde C K |
|
| 20:15 - 20:30 |
FINERENONE IN HEART FAILURE
|
SURAJ KHANAL |
|
| Adjourn |
